Share on Facebook
Share on Twitter
Share on LinkedIn

Many of the physicians and other experts who sit on FDA advisory panels to review medical devices have financial ties to manufacturers, but the regulator has failed to disclose the relationships, according to an analysis of corporate, state and federal data by The Wall Street Journal.

Read more.